References

1. AcrySof IQ Vivity^® Extended Vision IOL Directions for Use.
2. Alcon Data on File. US Patent 9968440 B2. 15 May 2018.
3. Bala C, et al. Multi-country clinical outcomes of a new nondiffractive presbyopia-correcting intraocular lens. J Cataract Refract Surg. 2021: Ahead of print. doi:10.1097/j.jcrs.0000000000000712
4. Alcon Data on File. TDOC-0055576. 23-Jul-2019
5. Alcon Data on File, TDOC-0056718. 18 Jun 2019.
6. Ligabue E, et al. ACRYSOF IQ VIVITY: Natural vision at a range of distances provided by a novel optical technology. Cataract & Refractive Surgery Today. April 2020.
7. Alcon Data on File. A02062-REP-043696, Optical Evaluations of Alcon Vivity^®, Symfony*, and Zeiss* AT LARA* IOLs.
8. Lawless M. Insight news. “An IOL to change the cataract surgery paradigm?” available at “https://insightnews.com.au/an-iol-to-change-the-cataract-surgery-paradigm/”. Accessed 17 Jul 2020.
9. Ike K. Ahmed, et al. The Vivity Extended Depth of Focus IOL: Our Clinical Experience. Cataract & Refractive Surgery Today. February 2021//
10. Braga-Mele R, et al. Multifocal intraocular lenses: relative indications and contraindications for implantation. J Cataract Refract Surg. 2014;40(2):313-322.
11. Gundersen KG, et al. Retreatments after multifocal intraocular lens implantation: an analysis. Clin Ophthalmol. 2016:10;365–371.
12. Zvornicanin J, et al. Premium intraocular lenses: The past, present and future. J Curr Ophthalmol. 2018;30(4):287-296.
13. Alcon Internal Memo, September 2020. REF-12576

적응증과 금기, 경고 등을 확인하려면, 관련 제품의 사용설명서를 참조하세요.